Document Detail

Selective renal vasodilation and active renal artery perfusion improve renal function in dogs with acute heart failure.
MedLine Citation:
PMID:  11504814     Owner:  NLM     Status:  MEDLINE    
Renal failure is common in heart failure due to renovascular constriction and hypotension. We tested whether selective pharmacological renal artery vasodilation and active renal artery perfusion (ARP) could improve renal function without adverse effects on systemic blood pressure in a canine model of acute heart failure (AHF). AHF was induced by coronary microembolization in 16 adult mongrel dogs. In five dogs, selective intrarenal (IR) papaverine (1, 2, and 4 mg/min) was administered into the left renal artery. In six dogs, ARP was performed in the left renal artery to normalize mean renal arterial pressure followed by administration of IR papaverine (2 mg/min). In five dogs, ARP plus intravenous furosemide was tested. Urine output (UO) and cortical renal blood flow decreased during AHF and were restored by 2 mg/min IR papaverine (UO: baseline 4.2 +/- 0.6, AHF 1.6 +/- 1.3, IR papaverine 5.8 +/- 1.1 ml/15 min; cortical blood flow: baseline 4.3 +/- 0.2, AHF 2.4 +/- 0.6, IR papaverine 4.2 +/- 1.2 ml/min/g) with no significant change in aortic pressure. ARP also increased urine output and cortical renal blood flow (UO: baseline 5.0 +/- 1.1, AHF 0.5 +/- 0.4, ARP 3.8 +/- 3.1 ml/15 min; cortical blood flow: baseline 4.0 +/- 0.5, AHF 2.0 +/- 0.8, ARP 3.52 +/- 1.1 ml/min/g). A combination of these methods in AHF further increased urine output to twice the normal baseline (10.5 +/- 7.5 ml/15 min). Addition of furosemide synergistically increased UO above that achieved with ARP alone (5.5 +/- 2.6 versus 40.3 +/- 24.7 ml/15 min, p = 0.03). In conclusion, ARP and selective renal vasodilation may effectively promote salt and water excretion in the setting of heart failure, particularly when systemic blood pressure is low.
K Suehiro; J Shimizu; G H Yi; A Gu; J Wang; G Keren; D Burkhoff
Related Documents :
17765144 - Renal versus extrarenal activation of vitamin d in relation to atherosclerosis, arteria...
6122514 - Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
11566964 - Pathophysiology of hypertension during preeclampsia linking placental ischemia with end...
8175174 - Pressure range for release of renomedullary depressor substance in rabbits.
16807514 - Beta blockers in portal hypertension. are they really a good option?
19210914 - Treatment of hypertension in acute ischemic stroke.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  298     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  2001 Sep 
Date Detail:
Created Date:  2001-08-15     Completed Date:  2001-09-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1154-60     Citation Subset:  IM    
The Cardiac Physiology Laboratory, Division of Circulatory Physiology, Department of Medicine, Columbia University, New York, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Diuretics / pharmacology
Drug Synergism
Furosemide / pharmacology
Heart Failure / physiopathology*
Kidney / physiopathology*
Papaverine / administration & dosage,  pharmacology
Renal Artery / physiology*
Renal Circulation / drug effects,  physiology*
Vasodilator Agents / administration & dosage,  pharmacology*
Reg. No./Substance:
0/Diuretics; 0/Vasodilator Agents; 54-31-9/Furosemide; 58-74-2/Papaverine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
Next Document:  Lusitropic effect of MCC-135 is associated with improvement of sarcoplasmic reticulum function in ve...